Pilar García‐Broncano

ORCID: 0000-0002-3413-2189
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • HIV Research and Treatment
  • Peptidase Inhibition and Analysis
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Immunotherapy and Immune Responses
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Galectins and Cancer Biology
  • T-cell and B-cell Immunology
  • Diabetes and associated disorders
  • Vitamin D Research Studies
  • Dendrimers and Hyperbranched Polymers
  • COVID-19 epidemiological studies
  • Reproductive System and Pregnancy
  • Advanced Breast Cancer Therapies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Agenus (United States)
2022-2024

Ragon Institute of MGH, MIT and Harvard
2017-2022

Brigham and Women's Hospital
2022

Instituto de Salud Carlos III
2013-2021

Centro Nacional de Microbiologia
2014-2021

Harvard University
2020

Hospital General Universitario Gregorio Marañón
2016-2019

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine
2017-2019

Jesse Fajnzylber James Regan Kendyll Coxen Heather Corry Colline Wong and 95 more Alexandra Rosenthal Daniel Worrall Françoise Giguel Alicja Piechocka‐Trocha Caroline Atyeo Stephanie Fischinger Andrew T. Chan Keith T. Flaherty Kathryn Hall Michael Dougan Edward T. Ryan Elizabeth Gillespie Rida Chishti Yijia Li Nikolaus Jilg Dusan Hanidziar Rebecca M. Baron Lindsey R. Baden Athe Tsibris Katrina Armstrong Daniel R. Kuritzkes Galit Alter Bruce D. Walker Xu G. Yu Jonathan Z. Li Betelihem A. Abayneh Patrick Allen Diane Antille Alejandro B. Balazs Julia Bals Max Barbash Yannic C. Bartsch Julie Boucau Siobhan Boyce Joan Braley Kelley R. Branch Katherine Broderick Julia Carney Josh Chevalier Manish C. Choudhary Navin Chowdhury Trevor Cordwell George Q. Daley Susan Davidson Michaël Desjardins Lauren Donahue David A. Drew Kevin Einkauf Sampson Elizabeth Ashley Elliman Behzad Etemad Jon Fallon Liz Fedirko Kelsey Finn Jeanne Flannery Pamela J. Forde Pilar García‐Broncano Elise Gettings David Golan Kirsten Goodman Amanda Griffin Sheila Grimmel Kathleen Grinke Ciputra Adijaya Hartana Meg Healy Howard M. Heller Deborah Henault Grace Holland Chenyang Jiang Hannah Jordan Paulina Kapłonek Elizabeth W. Karlson Marshall Karpell Chantal Kayitesi Evan C. Lam Vlasta LaValle Kristina Lefteri Xiaodong Lian Mathias Lichterfeld Daniel Lingwood Hang Liu Jin-Qing Liu K. A. J. Lopez Yuting Lu Sarah Luthern Ngoc L. Ly Maureen MacGowan Karen Magispoc Jordan Marchewka Brittani Martino Roseann McNamara Ashlin R. Michell Ilan Millstrom Noah Miranda Christian Nambu

The relationship between SARS-CoV-2 viral load and risk of disease progression remains largely undefined in coronavirus 2019 (COVID-19). Here, we quantify from participants with a diverse range COVID-19 severity, including those requiring hospitalization, outpatients mild disease, individuals resolved infection. We detected plasma RNA 27% hospitalized participants, 13% diagnosed COVID-19. Amongst the COVID-19, report that higher prevalence detectable is associated worse respiratory lower...

10.1038/s41467-020-19057-5 article EN cc-by Nature Communications 2020-10-30

Abstract Conventional immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) elicit durable survival but primarily in patients with immune-inflamed tumors. Although the mechanisms underlying response to anti–CTLA-4 remain poorly understood, Fc-gamma receptor (FcγR) IIIA coengagement seems critical for activity, potentially explaining modest clinical benefits of approved antibodies. We demonstrate that engineered enhanced FcγR affinity leverages FcγR-dependent...

10.1158/2159-8290.cd-24-0190 article EN cc-by-nc-nd Cancer Discovery 2024-07-31

Despite low plasma human immunodeficiency virus (HIV) RNA, HIV controllers have evidence of viral replication and elevated inflammation. We assessed the effect antiretroviral therapy (ART) on suppression, immune activation, quality life (QoL).A5308 was a prospective, open-label study rilpivirine/emtricitabine/tenofovir disoproxil fumarate in ART-naive (N = 35), defined as having RNA <500 copies/mL for ≥12 months. The primary outcome measured change %CD38+HLA-DR+ CD8+ T cells. Residual...

10.1093/cid/ciz442 article EN Clinical Infectious Diseases 2019-05-24

Highlights•ART initiation in neonates leads to a profound decline of intact HIV-1 proviruses•The longitudinal proviruses is linked NK cell responses•Initiation ART corrects innate immune perturbations ILCs and DCs•ILCs, macrophages, DCs are not associated with provirusesSummaryInitiation antiretroviral therapy (ART) infected within hours after birth limits viral reservoir seeding but does prevent long-term persistence. Here, we report parallel assessments cells antiviral responses unique...

10.1016/j.celrep.2022.111126 article EN cc-by Cell Reports 2022-07-01

Anionic carbosilane dendrons decorated with sulfonate functions and one thiol moiety at the focal point have been used to synthesize water-soluble gold nanoparticles (AuNPs) through direct reaction of dendrons, precursor, reducing agent in water, also a place-exchange reaction. These characterized by NMR spectroscopy, TEM, thermogravimetric analysis, X-ray photoelectron spectroscopy (XPS), UV/Vis elemental zeta-potential measurements. The interacting ability anionic was investigated EPR...

10.1002/chem.201504262 article EN Chemistry - A European Journal 2016-01-27

Objectives: Immune dysregulation is a hallmark of HIV and hepatitis C virus (HCV) infections. We aimed to evaluate the relationship between liver stiffness measurement (LSM) biomarkers T-cell activation, bacterial translocation, inflammation, endothelial dysfunction, coagulopathy in HIV/HCV-coinfected patients. Design: Cross-sectional study. Methods: studied 238 patients, 32 healthy controls, 39 HIV-monoinfected Patients were stratified according LSM into four groups: less than 12.5,...

10.1097/qad.0000000000001787 article EN AIDS 2018-02-12

Humoral responses in COVID-19 disease are often of limited durability, as seen with other human coronavirus epidemics. To address the underlying etiology, we examined postmortem thoracic lymph nodes and spleens acute SARS-CoV-2 infection observed absence germinal centers, a striking reduction Bcl-6+ center B cells but preservation AID+ cells. Absence centers correlated an early specific block Bcl-6+TFH&nbsp;cell differentiation together increase T-bet+TH1 aberrant extra-follicular TNF-a...

10.2139/ssrn.3652322 preprint EN SSRN Electronic Journal 2020-01-01

Interferon alpha (IFN-α) can potently reduce human immunodeficiency virus type 1 (HIV-1) replication in tissue culture and animal models, but may also modulate residual viral reservoirs that persist despite suppressive antiretroviral combination therapy. However, mechanisms leading to reservoir reduction during IFN-α treatment are unclear.We analyzed HIV-1 gag DNA levels CD4 T cells by digital droplet polymerase chain reaction CD8 T-cell natural killer (NK) cell phenotypes flow cytometry a...

10.1093/cid/cix1111 article EN Clinical Infectious Diseases 2017-12-18

Unprotected heterosexual intercourse is the first route for sustaining global spread of human immunodeficiency virus type 1 (HIV-1), being responsible 80% new HIV-1 infections in world.

10.1039/c7nr03034g article EN Nanoscale 2017-01-01
James Regan James P. Flynn Alexandra Rosenthal Hannah Jordan Yijia Li and 95 more Rida Chishti Françoise Giguel Heather Corry Kendyll Coxen Jesse Fajnzylber Elizabeth Gillespie Daniel R. Kuritzkes Nir Hacohen Marcia B. Goldberg Michael R. Filbin Xu G. Yu Lindsey R. Baden Ruy M. Ribeiro Alan S. Perelson Jessica M. Conway Jonathan Z. Li Betelihem A. Abayneh Patrick Allen Galit Alter Diane Antille Katrina Armstrong Alejandro B. Balazs Julia Bals Max Barbash Yannic C. Bartsch Julie Boucau Siobhan Boyce Joan Braley Kelley R. Branch Katherine Broderick Julia Carney Andrew Chan Josh Chevalier Fatema Z. Chowdhury George Q. Daley Susan Davidson Michael Dougan David Drew Kevin Einkauf Ashley Elliman Jon Fallon Liz Fedirko Kelsey Finn Keith T. Flaherty Jeanne Flannery Pamela J. Forde Pilar García‐Broncano Elise Gettings David Golan Amanda Griffin Sheila Grimmel Kathleen Grinke Kathryn Hall Ciputra Adijaya Hartana Meg Healy Howard M. Heller Deborah Henault Grace Holland Chenyang Jiang Nikolaus Jilg Paulina Kapłonek Marshall Karpell Chantal Kayitesi Evan C. Lam Vlasta LaValle Kristina Lefteri Xiaodong Lian Mathias Lichterfeld Daniel Lingwood Hang Liu Jin-Qing Liu Yiting Lu Sarah Luthern Natasha Ly Jordan Marchewka Britanni Martino Roseann McNamara Ashlin R. Michell Ilan Millstrom Noah Miranda Christian Nambu Susan C. Nelson Marjorie Noone Claire O’Callaghan Christine Ommerborn Mathew Osborn Lois Chris Pacheco Nicole Phan Shiv Pillai Falisha A. Porto Yelizaveta Rassadkina Alexandra Reissis Alex Rosenthal Francis F. Ruzicka Edward T. Ryan

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kinetics remain understudied, including the impact of remdesivir. In hospitalized individuals, peak sputum viral load occurred in week symptoms, whereas viremia peaked within 1 symptom-onset, suggesting early systemic seeding SARS-CoV-2. Remdesivir treatment was associated with faster decay.

10.1093/ofid/ofab153 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-04-17

Background: Eradication of hepatitis C virus (HCV) promotes an improvement in liver disease and the deactivation immune system. Here, we aimed to evaluate changes scores plasma biomarkers following HCV clearance with direct-acting antivirals (DAAs) HIV-infected patients advanced HCV-related cirrhosis. Methods: We performed observational study 50 cirrhosis who received DAAs therapy. Variables were assessed at baseline 48 weeks after treatment completion. Epidemiological clinical data...

10.3389/fmed.2021.615342 article EN cc-by Frontiers in Medicine 2021-02-01

The impact of very early infant treatment on human immunodeficiency virus (HIV) reservoir, and markers for success, require study.The Early Infant Treatment Study (EIT) enrolled 40 children living with HIV started antiretroviral (ART) at <7 days age, 23 who had between 30-365 to serve as controls. Quantitative DNA was evaluated every 1-3 months in peripheral blood mononuclear cells. 84-week repeat qualitative whole polymerase chain reaction dual enzyme immunosorbent assay were...

10.1093/cid/ciab143 article EN Clinical Infectious Diseases 2021-02-12

Background: Advanced cirrhosis is related to alterations in immunity. We aimed evaluate the levels of peripheral CD4+ T cells (Tregs) and plasma cytokine patients coinfected with human immunodeficiency virus hepatitis C (HIV/HCV) according liver fibrosis stages [evaluated as stiffness measure (LSM)] their linear relationship. Methods: performed a cross-sectional study on 238 HIV/HCV-coinfected (119 had &lt;12.5 kPa, 73 12.5–25 46 &gt;25 kPa). Peripheral T-cell subsets were phenotyped by flow...

10.3390/cells7110196 article EN cc-by Cells 2018-11-02

The IL7RA polymorphisms have recently been associated with CD4+ T-cell decline in untreated HIV-infected subjects and recovery patients on combination antiretroviral therapy (cART). aim of this study was to evaluate whether are long-term cART.We performed a retrospective 151 naïve cART severe immunodeficiency (CD4+ counts ≤200 cells/mm(3) ). polymorphisms' genotyping using Sequenom's MassARRAY platform. outcome variable the time achieve first value count ≥500 during follow-up.Two different...

10.1111/eci.12539 article EN European Journal of Clinical Investigation 2015-09-24

Abstract Background The adiponectin ( ADIPOQ ) rs2241766 polymorphism is related to metabolic abnormalities. aim of this study was evaluate the association with serum dyslipidemia and insulin resistance IR in human immunodeficiency virus HIV )/hepatitis C HCV )‐coinfected patients. Methods We carried out a cross‐sectional on 262 polymorphisms were genotyped by GoldenGate ® assay. Generalized linear models GLMs used compare continuous outcome variables (total cholesterol TC ), triglycerides...

10.1111/eci.12250 article EN European Journal of Clinical Investigation 2014-02-17

Interleukin-7 (IL-7) is a critical factor for T cell development and maintaining restoring homeostasis of mature cells. Polymorphisms at α-chain the IL-7 receptor (IL7R or CD127) gene are related to evolution HIV-infection, but there no data concerning hepatitis C virus (HCV) infection. The aim this study was analyze association between IL7R polymorphisms severe liver disease in HCV/HIV coinfected patients. We performed cross-sectional 220 naïve patients who underwent biopsy. (rs6897932,...

10.1186/s12967-015-0577-y article EN cc-by Journal of Translational Medicine 2015-06-29

The Fat Mass and Obesity-Associated Protein (FTO) gene rs9939609 single nucleotide polymorphism (SNP) has been associated with obesity, metabolic syndrome, insulin resistance (IR), type 2 diabetes mellitus in the general population. aim of our study was to examine for first time association disturbances, liver disease virologic response hepatitis C virus (HCV) therapy pegylated-interferon-alpha plus ribavirin (pegIFNα/RBV) human immunodeficiency (HIV)/HCV coinfected patients. We carried out...

10.1186/s12916-014-0198-y article EN cc-by BMC Medicine 2014-11-03

Abstract We aimed to evaluate the association of plasma biomarkers linked inflammation (bacterial translocation, inflammatory response, and endothelial dysfunction), coagulopathy, angiogenesis with severity liver cirrhosis (assessed by Child-Pugh-Turcotte score, CTP) Child-Pugh B (CTP 7–9) in patients advanced hepatitis C virus (HCV)-related cirrhosis. carried out a cross-sectional study 97 HCV-related (32 HCV-monoinfected 65 HIV/HCV-coinfected). Plasma were measured ProcartaPlex multiplex...

10.1038/s41598-020-67159-3 article EN cc-by Scientific Reports 2020-06-25

To analyze the relationship of SLC30A8 rs13266634 polymorphism with insulin resistance and dyslipidemia in HIV/hepatitis C virus (HCV)-coinfected patients.Cross-sectional study 260 HIV/HVC-coinfected patients.SLC30A8 polymorphisms were genotyped by GoldenGate assay. Genetic data analyzed under dominant inheritance model (CT/TT versus CC). Cholesterol, triglycerides, high-density lipoprotein (HDL-C), low-density (LDL-C), LDL-C/HDL-C, atherogenic index, homeostatic assessment (HOMA-IR) values...

10.1097/qad.0000000000000215 article EN AIDS 2014-02-05

BackgroundThe persistence of HIV-1-infected cells during antiretroviral therapy is well documented but may be modulated by early initiation in infants.MethodsHere, we longitudinally analyzed the proviral landscape nine infants with vertical HIV-1 infection from Mozambique over a median period 24 months, using single-genome, near full-length, next-generation sequencing.ResultsWe observed rapid decline frequency intact proviruses, leading to disproportional under-representation sequences...

10.1016/j.ijid.2022.11.042 article EN cc-by-nc-nd International Journal of Infectious Diseases 2022-12-05
Coming Soon ...